title: Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue.
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
authors.forename: Yavuz S
authors.initials: YS
authors.lastname: Silay
authors.forename: Ozden
authors.initials: O
authors.lastname: Altundag
authors.forename: Mustafa A
authors.initials: MA
authors.lastname: Atik
authors.forename: Serdal
authors.initials: S
authors.lastname: Aktolga
mesh_terms: D050071:Bone Density Conservation Agents / Q000494:pharmacology; D001940:Breast / Q000378:metabolism / Q000473:pathology*; D001941:Breast Diseases / Q000209:etiology*; D002114:Calcinosis / Q000209:etiology*; D002118:Calcium / Q000378:metabolism; D002128:Calcium Metabolism Disorders; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D017698:Postmenopause
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D002118:Calcium